1. Pink Sheet
  2. >>Geography
  3. >>Europe

EMA Moves To Boost Use Of Alternatives To Animal Testing

 
• By Neena Brizmohun

Alternative approaches to animal models, such as improved tests based on human and animal cells, provide opportunities to develop better and more predictive scientific tools, the European Medicines Agency says.

Organ-on-a-chip (OOC) - microfluidic device chip that simulates biological organs that is type of artificial organ. Prototype of design lab-on-a-chip
Organ-on-chips technology can provide an alternative to animal models • Source: Alamy

The European Medicines Agency has implemented a new measure to minimize animal testing by making its free-of-charge Innovation Task Force (ITF) available to companies for discussions on how to replace, reduce and refine animal use during the development, manufacturing and testing of human and veterinary medicines.

Alternative approaches to animal models include improved tests based on human and animal cells, organoids, organ-on-chips and in silico modeling....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EU Health Chief Declares There Is No Better Alternative Than TEVs to Spark Antibiotic Innovation

 
• By Francesca Bruce

Clarity on what transferable exclusivity vouchers may look like for new antimicrobial drugs could be nearing. Denmark’s new presidency of the Council of the EU has prioritized concluding its negotiations with European Parliament over the legislative overhaul of the EU’s pharmaceutical legislation.

EU Fines Alchem Over Buscopan API Cartel

 
• By Dave Wallace

After pursuing Alchem International for breaches of EU antitrust rules – relating to a cartel over the SNBB pharmaceutical ingredient used in Buscopan and its generics – the European Commission has now hit the firm with a €489,000 fine.

Bayesian Statistics In EU Clinical Trials: EMA Discusses Balancing Efficiency With Rigor

 
• By Eliza Slawther

Bayesian statistics could help clinical trial sponsors to include external information in their analyses, but concerns around bias and incorrect conclusions remain, the European Medicines Agency said.